Clinical Trial

The Treatment of Newly Diagnosed CD19+Mixed Phenotype Acute Leukemia in Adults

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
Evaluation the efficacy and safety of the combination of injectable bevacizumab, low-intensity chemotherapy, and venula in the treatment of newly diagnosed CD19+mixed phenotype acute leukemia in adults
Trial Details
NCT Number NCT06876701
Lead Sponsor Ruijin Hospital
Conditions Acute Leukemia
Enrollment 10 participants
Start Date 2025-04-01
Primary Completion 2027-04-01 (estimated)
Study Completion 2027-04-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-14